Kelley Shannon T. - 17 Aug 2026 Form 4 Insider Report for MADRIGAL PHARMACEUTICALS, INC. (MDGL)

Reporting relationship: General Counsel
Issuer ticker: MDGL
Reported as of: 17 Aug 2026
Net transaction value: -$341,940
SEC form: 4
Accepted by SEC: 20 Aug 2026, 16:20:52 UTC
Prior SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Mardi Dier, as Attorney-in-Fact

Key filing fact

Kelley Shannon T. filed Form 4 for MADRIGAL PHARMACEUTICALS, INC. (MDGL) on 20 Aug 2026.

Key facts

This page summarizes Kelley Shannon T.'s Form 4 filing for MADRIGAL PHARMACEUTICALS, INC. (MDGL).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Aug 2026, 16:20.

Change

Previous filing in this sequence was filed on 06 Mar 2026.
Current net transaction value: -$341,940.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002034056 Primary reporting owner

Kelley Shannon T

Relationship: General Counsel
Address: C/O MADRIGAL PHARMACEUTICALS, INC., 1001 CONSHOHOCKEN STATE ROAD SUITE 2-350, WEST CONSHOHOCKEN
Signature: /s/ Mardi Dier, as Attorney-in-Fact
Signature date: 20 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDGL transaction

Common Stock

Sale

Transaction value: $341,940
Shares: -664
Change %: -5.5%
Price: $514.97
Shares after: 11,474
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.